Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress

Neuroendocrinology

Volumn 86, Issue 1, 2007, Pages 17-25

  Pournajafi Nazarloo, Hossein ^a,b   Partoo, Leila ^a   Sanzenbacher, Lisa ^a   Azizi, Fereidoun ^a   Carter, C Sue ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cardiovascular system; Corticotropin releasing hormone receptor; Stress; Urocortins

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MESSENGER RNA; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 1; UROCORTIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRAIRIE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOCIAL ISOLATION; UPREGULATION;

ACUTE DISEASE; ANIMALS; ARVICOLINAE; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; MALE; MYOCARDIUM; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; SOCIAL ISOLATION; STRESS; UROCORTINS;

EID: 34547624665     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103587     Document Type: Article

References (42)

1. Vale W, Spiess J, Rivier C, Rivier J: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981;213:1394-1397.
2. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W: Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995;378:287-292.
3. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale W, Sawchenko PE: Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 2001;98:2843-2848.
4. Hsu SY, Hsueh AJ: Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 2001;7:605-611.
5. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale W: Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 2001;98:7570-7575.
6. Cang CP, Pearse RI, O'Connell S, Rosenfeld MG: Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993;11:1187-1195.
7. Perrin MH, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko PE, Vale W: Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995;92:2969-2973.
8. Kishimoto T, Pearse RV, Lin CR, Rosenfeld MG: A sauvagine/corticotropin- releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995;92:1108-1112.
9. Kostich WA, Chen A, Sperle K, Largent BL: Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol Endocrinol 1998;12:1077-1085.
10. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian L, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF: Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998;20:1093-1102.
11. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul M, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W: Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 1998;19:162-166.
12. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale W, Lee KF: Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000;24:410-414.
13. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP: Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000;24:403-409.
14. Kageyama K, Gaudriault GE, Bradbury MJ, Vale W: Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. Endocrinology 2000;141:2285-2293.
15. Heldwein KA, Duncan JE, Rittenberg MB, Stenzel P, Stenzel-Poore MP: Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle. Mol Cell Endocrinol 1997;31:167-172.
16. Coste SC, Heldwein KA, Stevens SL, Tobar-Dupres E, Stenzel-Poore MP: IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology 2001;142:3537-3545.
17. Nazarloo HP, Nishiyama M, Tanaka Y, Asaba K, Hashimoto K: Down-regulation of corticotropin-releasing hormone receptor type 2beta mRNA expression in the rat cardiovascular system following food deprivation. Regul Pept 2002;105:121-129.
18. Pournajafi Nazarloo H, Tanaka Y, Dorobantu M, Hashimoto K: Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart. Regul Pept 2003;115:131-138.
19. Gardiner SM, March JE, Kemp PA, Bennett T: A comparison between the cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin related peptide) in conscious rats. J Pharmacol Exp Ther 2007;321:221-226.
20. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjos OD, Latchman DS, Lee KF, Vale W: Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 2004;145:24-35.
21. Yang LZ, Kockskamper J, Heinzel FR, Hauber M, Walther S, Spiess J, Pieske B: Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A. Cardiovasc Res 2006;69:402-411.
22. Das S, O'Keefe JH: Behavioral cardiology: recognizing and addressing the profound impact of psychosocial stress on cardiovascular health. Curr Atheroscler Rep 2006;8:111-118.
23. Carter CS: Developmental consequences of oxytocin. Physiol Behav 2003;79:383-397.
24. Carter CS, DeVries AC, Getz LL: Physiological substrates of mammalian monogamy: the prairie vole model. Neurosci Biobehav Rev 1995;19:303-314.
25. Keverne EB, Curley JP: Vasopressin, oxytocin and social behaviour. Curr Opin Neurobiol 2004;14:777-783.
26. Grippo AJ, Lamb DG, Carter CS, Porges SW: Cardiac regulation in the socially monogamous prairie vole. Physiol Behav 2007;90:386-393.
27. Grippo AJ, Cushing BS, Carter CS: Depression-like behavior and stressor-induced neuroendocrine activation in female prairie voles exposed to chronic social isolation. Psychosom Med 2007;69:149-157.
28. Taymans SE, DeVries AC, DeVries MB, Nelson RJ, Friedman TC, Castro M, Detera-Wadleigh S, Carter CS, Chrousos GP: The hypothalamic-pituitary-adrenal axis of prairie voles (Microtus ochrogaster): evidence for target tissue glucocorticoid resistance. Gen Comp Endocrinol 1997;106:48-61.
29. Auffray C, Rougeon F: Nucleotide sequence of a cloned cDNA corresponding to secreted mu chain of mouse immunoglobulin. Eur J Biochem 1980;107:303-314.
30. Pournajafi Nazarloo H, Takao T, Nanamiya W, Asaba K, De Souza EB, Hashimoto K: Effect of non-peptide corticotropin-releasing factor receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress. Brain Res 2001;902:119-126.
31. Irvine RJ, White J, Chan R: The influence of restraint on blood pressure in the rat. J Pharmacol Toxicol Methods 1997;38:157-162.
32. Gardiner SM, Kemp PA, March JE, Woolley J, Bennett T: The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Br J Pharmacol 1998;125:1543-1550.
33. Heldwein KA, Redick DL, Rittenberg MB, Claycomb WC, Stenzel-Poore MP: Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 1996;137:3631-3639.
34. Terui K, Higashiyama A, Horiba N, Furukawa KI, Motomura S, Suda T: Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J Endocrinol 2001;169:177-183.
35. Weninger SC, Peters LL, Majzoub JA: Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology 2000;141:256-263.
36. Kageyama K, Bradbury MJ, Zhao L, Blount AL, Vale W: Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 1999;140:5651-5658.
37. Parkes DG, Vaughan J, Rivier J, Vale W, May CN: Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 1997;272(5 Pt 2):H2115-H2122.
38. Asaba K, Makino S, Nishiyama M, Hashimoto K: Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin. J Cardiovasc Pharmacol 2000;36:493-497.
39. Smit MJ, Roovers E, Timmerman H, van de Vrede Y, Alewijinse AE, Leurs R: Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 → Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists. J Biol Chem 1996;271:7574-7582.
40. Bamberger CM, Wald M, Bamberger AM, Ergun S, Beil FU, Schulte HM: Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 1998;83:708-711.
41. Bale TL, Giordano FJ, Vale W: A new role for corticotropin-releasing factor receptor-2: suppression of vascularization. Trends Cardiovasc Med 2003;13:68-71.
42. Rademaker MT, Cameron VA, Charles CJ, Richards AM: Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 2005;112:3624-3632.